603 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
aspects and typically have one or more of the following characteristics, such as being highly variable, difficult to project, unusual in nature, significant
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
18 Mar 24
Strengthening Neuroscience Portfolio
8:56am
, difficult to project, unusual in nature, significant to the results of a particular period or not indicative of past or future operating results
8-K
EX-1.1
76l3l6ekzbzn9f shvk
22 Feb 24
Other Events
4:15pm
424B5
xn8wft1
16 Feb 24
Prospectus supplement for primary offering
4:34pm
FWP
6wmvq1epynng
14 Feb 24
Free writing prospectus
9:07pm
424B2
qxna bjueneerx35
13 Feb 24
Prospectus for primary offering
8:00am
8-K
EX-99.1
zwmbv4lem jiqla1qpr7
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
r6bw2p ps
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
8ibaw3 cmtud
25 Jan 24
Third party tender offer statement
8:13am